INOVIO PHARMACEUTICALS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
INOVIO PHARMACEUTICALS, INC. (INO) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $11.42 million as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2025-08-12
- 2025-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $11.42M.
- 2025-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $9.54M.
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $13.26M.
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2025-06-30 | $11.42M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $9.54M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $13.26M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-18 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $119.80B 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $22.04B 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $8.82M 10-K · filed 2021-03-01 | $8.82M 10-K · filed 2020-03-12 |
| 2019-09-30 | $4.50B 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |